PA
MD icon

Procyon Advisors’s Pediatrix Medical MD Stock Holding History

Procyon Advisors’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+9,366
New +$213K 0.01% 515
2020
Q3 		– Sell
-7
Closed – – 700
2020
Q2 		$0 Hold
7
– – ﹤0.01% 1143
2020
Q1 		$0 Hold
7
– – ﹤0.01% 1096
2019
Q4 		$0 Buy
+7
New +$176 ﹤0.01% 1040

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Procyon Advisors's MD Position: Q2 2026 in Review

Procyon Advisors opened a new position in Pediatrix Medical (MD) in Q2 2026: 9,366 shares worth $237K. The stake represents 0.01% of the portfolio and ranks #515 among its holdings. This is a return to the name: Procyon Advisors previously reported a position in MD as recently as Q2 2020.

Procyon Advisors first reported a position in MD in Q4 2019 and has held it in 4 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Procyon Advisors held 9,366 shares of Pediatrix Medical worth $237K as of Q2 2026.
  • Pediatrix Medical was a new Procyon Advisors position in Q2 2026.
  • Pediatrix Medical made up 0.01% of Procyon Advisors's portfolio in Q2 2026, its #515 holding.
  • Procyon Advisors first reported a position in Pediatrix Medical in Q4 2019 and has held it in 4 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.